Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Imbio provides regulatory-cleared, fully automated AI solutions that transform standard chest CT images into quantitative visual maps and reports. These tools support diagnosis, treatment planning, monitoring of progression or response to therapy in a range of pulmonary and cardiothoracic diseases. Their technology has been validated on thousands of patients and integrated into routine clinical workflows globally. In December 2023, Imbio was acquired by Australian company 4DMedical to create a comprehensive suite for anatomical/tissue plus functional cardiothoracic imaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Imbio.